Jobs / United States / Astrazeneca Pharmaceuticals Lp
Medical Affairs Director, US Rare Nephrology
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Boston - MA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles4 certified filings for “Associate Director, Precision Medicine” (Medical Scientists, Except Epidemiologists) in MA: $179k–$260k, median $215k. Most were filed at wage level II (75%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
In collaboration with US and global medical and cross-functional colleagues, the Medical Director will lead the development and implementation of the aHUS strategic medical plan for US Medical Affairs, providing medical leadership, insights, and strategic direction across functions. Responsible for the following: • Leading the development and implementation of the US strategy and plan for US MA activities for aHUS by providing medical leadership, insight and strategic guidance to the US aHUS medical team. • In partnership with the Executive Medical Director, providing medical strategic and tactical plans for late-phase pipeline program for Rare Nephrology as well as future LCM and potential late phase pipeline programs in the therapeutic area. • Leading the situational assessment of the patient journey and the US product strategy development including harmonization of activities involving KOLs cross-functionally. • Developing in-year medical strategy and tactical plan for the US Medical Affairs team for aHUS • Contributing scientific and medical acumen as well as the US perspective to registration programs working closely with GMA • Providing medical review and assurance of alignment with aHUS/Rare Nephrology strategic areas of interest for Investigator Sponsored Research (ISR) proposals. • Providing medical guidance, as appropriate, regarding scientific communication, internal medical training, external medical education (CME, Symposia, medical education), Medical Information. • Providing strategic medical leadership and appropriate medical input to cross-functional brand strategy • Support Head of US Rare Hematology & Nephrology with team’s performance in terms of goals and delivery of US medical plans. • Serving as a medical expert and resource within Alexion in support of the therapeutic area. • Leading content development and presentation for external medical education programs and other medical initiatives. • Developing, conducting, or contributing to therapeutic training programs for Alexion personnel. • Establishing strategic partnerships with Centers of Excellence and KOLs in areas of scientific interest and serving as a conduit for flow of information both out to the medical community and into the company. • Working closely with the Field Medical Team (Medical Science Liaisons and Field Directors) in the development and execution of US KOL medical engagement strategy as well as the development and implementation of the field medical strategic plan. • Establishing and/or enhancing partnerships with key academic institutions and developing relationships with key thought leaders. • Planning, designing and managing medical Advisory Boards and gathering insight from national/regional/local medical Advisory Boards or other insight-gathering activities. • Contribute to collaborations and engagements with professional societies and patient advocacy organizations in the therapeutic area You will need to have: • Must have an MD, PhD or PharmD level degree or equivalent- Nephrology, Hematology, or Immunology experience would be a plus. • Significant experience in Medical Affairs and/or the biopharmaceutical industry, including development and execution of medical strategy. • Deep scientific and clinical expertise with the ability to translate complex data into strategic medical insights. • Demonstrated success leading cross-functional initiatives and influencing senior stakeholders in a matrix environment. • Strong understanding of the US healthcare, regulatory, and reimbursement landscape. • Proven ability to establish and maintain productive relationships with KOLs, academic institutions, professional societies, and external healthcare stakeholders. The annual base pay for this position ranges from $206